Compugen (CGEN) Short-term Investments (2009 - 2026)
Compugen (CGEN) reported Short-term Investments of $79.3 million for Q1 2026, up 40.43% on a YoY basis from $56.5 million in Q1 2025, and up 73.33% sequentially from $45.8 million in Q4 2025.
Compugen (CGEN) Short-term Investments (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Short-term Investments data on file, last reported at $79.3 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments rose 40.43% year-over-year to $79.3 million; the trailing twelve-month figure through Mar 2026 stood at $79.3 million (up 40.43% YoY), and the FY2025 full-year result was $45.8 million, down 25.47% from the prior year.
- Short-term Investments rose to $79.3 million in Q1 2026, from $45.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $88.9 million in Q2 2022 to a low of $25.1 million in Q4 2023.
- A 5-year average of $57.4 million and a median of $56.5 million in 2025 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments tumbled 50.18% in 2023 and soared 145.07% in 2024, its largest moves.
- Tracing CGEN's Short-term Investments over 5 years: stood at $88.9 million in 2022, then plunged by 71.82% to $25.1 million in 2023, then soared by 145.07% to $61.4 million in 2024, then decreased by 25.47% to $45.8 million in 2025, then soared by 73.33% to $79.3 million in 2026.
- Business Quant data shows CGEN's Short-term Investments at $79.3 million in Q1 2026, $45.8 million in Q4 2025, and $51.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.32 Mn |
| Dec 31, 2025 | 45.76 Mn |
| Sep 30, 2025 | 51.91 Mn |
| Jun 30, 2025 | 58.54 Mn |
| Mar 31, 2025 | 56.48 Mn |
| Dec 31, 2024 | 61.40 Mn |
| Sep 30, 2024 | 72.35 Mn |
| Jun 30, 2024 | 47.44 Mn |
| Dec 31, 2023 | 25.05 Mn |
| Jun 30, 2023 | 44.30 Mn |
| Jun 30, 2022 | 88.92 Mn |
| Dec 31, 2021 | 109.25 Mn |
| Jun 30, 2021 | 102.56 Mn |
| Dec 31, 2020 | 116.62 Mn |
| Jun 30, 2020 | 122.96 Mn |
| Dec 31, 2019 | 34.04 Mn |
| Jun 30, 2019 | 30.75 Mn |
| Dec 31, 2018 | 39.21 Mn |
| Jun 30, 2018 | 32.15 Mn |
| Dec 31, 2017 | 3.92 Mn |